fda warning bpc-157 not approved Four-of-seven unapproved peptides get the green light from panel bpc-157 safety fda status not

For use in vitamin B12 deficiency associated with cobalt deficiency in cattle and sheep and for vitamin B12 deficiency associated with inadequate vitamin B12 intake or intestinal malbsorption in swine and horses.

The 1ml option works well for experienced users who need smaller injection volumes or are on higher doses

These effects can include fatigue and weakness, numbness and tingling in the hands and feet, and memory loss and cognitive decline

NICE guidelines recommend hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks (without neurological involvement) or on alternate days until no further improvement (with neurological symptoms)